DCTH
HealthcareDelcath Systems, Inc.
$10.26
+$0.31 (+3.12%)
Jan 5, 2026
Price History (1Y)
Analysis
Delcath Systems, Inc. operates in the Healthcare sector and Medical Devices industry, with a market capitalization of $362.32 million and 96 employees. The company's revenue has grown by 83.6% year-over-year, reaching $79.60 million in the trailing twelve months. Financially, Delcath Systems, Inc. reported an operating margin of -1.9%, a profit margin of 1.5%, and a return on equity (ROE) of 1.9%. The company's balance sheet shows cash holdings of $88.91 million and debt of $965,000. The current ratio is 15.06, indicating sufficient liquidity to meet short-term obligations. Valued at a price-to-earnings (P/E) ratio of 342.00, Delcath Systems, Inc. has a forward P/E of 20.94 and an earnings growth rate of -66.7% year-over-year. The company's gross margin is 86.3%, while the return on assets (ROA) is 4.7%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Delcath Systems, Inc.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1987 and is headquartered in New York, New York.
Visit website →Key Statistics
- Market Cap
- $362.32M
- P/E Ratio
- 342.00
- 52-Week High
- $18.23
- 52-Week Low
- $8.12
- Avg Volume
- 848.31K
- Beta
- 0.39
Company Info
- Industry
- Medical Devices
- Exchange
- NCM
- Country
- United States
- Employees
- 96